Psychiatr Serv. 2004 Mar;55(3):221.

Datapoints: Trends in naltrexone use among members of a large private health plan.

Source

Substance Abuse and Mental Health Services Administration, NIMH/NIH, 5600 Fishers Lane, Room 16-105, Rockville, MD 20857, USA. kharris@samhsa.gov

PMID:: 15001719; [PubMed - indexed for MEDLINE]

MeSH Terms, Substances

MeSH Terms

Substances

Naltrexone

LinkOut - more resources

Full Text Sources

Supplemental Content

Icon for Silverchair Information Systems

Save items

Related citations in PubMed

I get no kick from CH3CH2OH. [Sci Am. 1995]
I get no kick from CH3CH2OH.
Nemecek S. Sci Am. 1995 Apr; 272(4):24, 26.
[USA approves of a new drug that decreases the craving for alcohol]. [Lakartidningen. 1995]
[USA approves of a new drug that decreases the craving for alcohol].
Wirschubsky ZG. Lakartidningen. 1995 Mar 8; 92(10):1005.
From the National Institutes of Health. [JAMA. 1994]
From the National Institutes of Health.
Gordis E. JAMA. 1994 Dec 14; 272(22):1733.
Review Extended-release intramuscular naltrexone: a viewpoint by Falk Kiefer. [Drugs. 2006]
Review Extended-release intramuscular naltrexone: a viewpoint by Falk Kiefer.
Kiefer F. Drugs. 2006; 66(13):1752-3.
Review Vivitrex (Alkermes/Cephalon). [Curr Opin Investig Drugs. 2006]
Review Vivitrex (Alkermes/Cephalon).
Heading CE. Curr Opin Investig Drugs. 2006 Jan; 7(1):81-8.

See reviews... See all...

Cited by 6 PubMed Central articles

Extended-release naltrexone for alcohol dependence: persistence and healthcare costs and utilization. [Am J Manag Care. 2011]
Extended-release naltrexone for alcohol dependence: persistence and healthcare costs and utilization.
Bryson WC, McConnell J, Korthuis PT, McCarty D. Am J Manag Care. 2011 Jun; 17 Suppl 8:S222-34.
Early adoption of injectable naltrexone for alcohol-use disorders: findings in the private-treatment sector. [J Stud Alcohol Drugs. 2010]
Early adoption of injectable naltrexone for alcohol-use disorders: findings in the private-treatment sector.
Abraham AJ, Roman PM. J Stud Alcohol Drugs. 2010 May; 71(3):460-6.
Effects of naltrexone treatment for alcohol-related disorders on healthcare costs in an insured population. [Alcohol Clin Exp Res. 2010]
Effects of naltrexone treatment for alcohol-related disorders on healthcare costs in an insured population.
Kranzler HR, Montejano LB, Stephenson JJ, Wang S, Gastfriend DR. Alcohol Clin Exp Res. 2010 Jun; 34(6):1090-7. Epub 2010 Apr 5.

See all...

Related information

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.

Recent activity

Clear Turn Off Turn On

Datapoints: Trends in naltrexone use among members of a large private health pla...
Datapoints: Trends in naltrexone use among members of a large private health plan.
Psychiatr Serv. 2004 Mar ;55(3):221.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

PubMed

Result Filters

Display Settings:

Send to:

Datapoints: Trends in naltrexone use among members of a large private health plan.

Source

MeSH Terms, Substances

MeSH Terms

Substances

LinkOut - more resources

Full Text Sources

Other Literature Sources

Medical

Molecular Biology Databases

Supplemental Content

Save items

Related citations in PubMed

Cited by 6 PubMed Central articles

Related information

Recent activity

Simple NCBI Directory

Getting Started

Resources

Popular

Featured

NCBI Information